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means of helical tomotherapy (HTT), with a simultaneous 
integrated boost (SIB) on FDG-positive volumes (BTV). 
 
Material and Methods: 41 patients (median age: 60; range: 
41-81) treated between November 2005 and April 2014 at our 
Institution for advanced squamocellular oropharyngeal 
disease were analyzed. Most of the patients (95%) were of 
stage III-IV; 38 patients had positive lymph nodes (N, 32 with 
more than one N). HTT was delivered with a SIB approach in 
30 fractions at different dose levels, concomitantly: 69 Gy 
(2.3 Gy/day) to FDG-positive volumes ( primary tumor (T) and 
N ), 66 Gy (2.2 Gy/day) to the tumor volume and enlarged 
nodes and 54 Gy (1.8 Gy/day) to the subclinical and elective 
treated nodes. PET metabolic parameters of FDG-positive 
volumes (T, N and T+N), including maximum and mean 
standardized uptake value (SUVmax and SUVmean), 
metabolic tumor volume (MTV) estimated at different 
thresholds 40-50-60% (MTV-40, MTV-50, MTV-60) and total 
lesion glycolysis (TLG-40, TLG-50, TLG-60) were considered. 
BTV volumes for T (BTV-T), N (BTV-N) and T+N (BTV-T+N) 
were also considered. Log rank univariate and Cox regression 
multivariate analysis were used to evaluate prognostic values 
of PET derived parameters and cancer specific overall 
survival (CSOS), local recurrence-free survival (LRFS) and 
loco-regional recurrence –free survival (LNRFS). The best cut-
off values of PET derived parameters discriminating between 
patients with/without death/relapse were assessed by ROC 
analysis. 
 
Results: The median follow-up was 37 months (range: 3-125 
months). The 3-year CSOS, LRFS and LNRFS were 88.5%, 85% 
and 80%, respectively. At univariate analysis MTV-T-60>4.4cc 
was found the most significant PET parameter correlated to 
CSOS (HR: 0.09, p=0.0078), LRFS (HR: 0.07, p=0.0017) and 
LNRFS (HR: 0.16, p=0.01). TLG-T-60, SUVmean(T+N), MTV-
T+N-60 were also found to be correlated with CSOS and LRFS. 
At multivariate analysis BTV-T+N>30.9cc and MTV-T-60>4.4cc 
were found the variables most significantly correlated with 
CSOS (AUC: 0.885; 95%CL: 0.739-0.965). MTV-T-60>4.4cc 
confirms its independent predictive role for LRFS (AUC: 
0.807; 95%CL: 0.647-0.917) and for LNRFS (AUC: 0.744; 
95%CL: 0.577-0.872). 
 
 
Conclusion: FDG PET/CT performed as guide for HTT SIB 
treatment in patients affected by advanced oropharyngeal 
cancer is predictive of patient’s outcome. MTV-T-60 was 
found the best predictor for CSOS, LRFS and LRNFS. FDG-
PET/CT image-derived parameters might be useful to select 
more personalized treatment strategies. 
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Purpose or Objective: Both the standardized uptake value 
(SUV), acquired by 18F-flurodeaxyglucose positron emission 
tomography/computed tomography (18F-FDG PET/CT), and 
the apparent diffusion coefficient (ADC) acquired by 
diffusion-weighted magnetic resonance imaging (DW-MR) are 
well established measures for treatment response assessment 
in neoadjuvant esophageal cancer treatment. However, these 
functional imaging parameters may refer to different aspects 
of tumor pathophysiology. Currently it is unclear whether 
these two prognostic biomarkers provide similar information 
or represent independent biomarkers. Therefore the aim of 
this study was to evaluate the correlation between SUV and 
ADC measurements in untreated esophageal tumors. 
 
Material and Methods: This prospective study included 33 
patients with histologically proven esophageal cancer who 
underwent 18F-FDG PET/CT and DW-MR examinations within 
3 weeks before therapy. Tumor glucose metabolism was 
evaluated by the maximum and mean SUV (SUVmax and 
SUVmean) on the 18F-FDG PET/CT images. Minimum and 
mean ADC values (ADCmin and ADCmean, calculated with b 
values of 0,200 and 800 s/mm2) were measured in the same 
lesions. Lesions with a diameter larger than 3 cm were 
matched and a voxelwise analysis of ADC and SUV was 
performed. Spearman’s rank correlation coefficients were 
used to assess the correlation between 18F-FDG PET and ADC 
metrics. Also the tumor ADCmean and SUVmax was compared 
between squamous cell carcinomas and adenocarcinomas, 
and between moderately and poorly differentiated tumors. 
 
Results: Mean ADCmean and ADCmin of the 33 included 
esophageal cancer tumors were 1.8 ± 0.4 and 0.8 ± 0.4, *10-
3mm2/s, respectively. Mean SUVmean and Mean SUVmax 
were 8.3 ± 4.2 and 17.4 ± 9.6, respectively. The SUV and ADC 
values as measures of glucose metabolism and cell density, 
respectively, showed weak to very weak non-significant 
correlations only (ADCmin vs SUVmax; r=0.30, p=0.09], 
[ADCmin vs. SUVmean r=0.30 p=0.09], [ADCmean vs SUVmax 
r=0.17 p=0.36], [ADCmean vs SUVmean r=0.14 p=0.43]) 
(Figure 1). The voxel-wise analysis of 16 esophageal tumors 
with diameters larger than 3 cm showed a weak but 
significant negative correlation between ADC and SUV in 11 
patients. ADCmean was significantly related to histological 
tumor grade (2.0 ± 0.3 in moderately differentiated tumors 
vs. 1.6 *10-3mm2/s in poorly differentiated tumors 
(p=0.014)). No difference between squamous cell carcinoma 
and adenocarcinoma was found. SUVmax showed no 
differences with regard to tumor type and differentiation 
grade. 
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Conclusion: This study indicates that both glucose 
metabolism measured by PET/CT and restriction measured by 
DW-MR are independent cellular phenomena in newly 
diagnosed esophageal cancer. Therefore, SUV with ADC 
values may have complementary roles as imaging biomarkers 
in the evaluation of survival and response to neoadjuvant 
treatment in esophageal cancer. 
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Purpose or Objective: To determine molecular subtypes of 
breast cancers using texture-feature-driven machine learning 
techniques on mammographic images. 
 
Material and Methods: We used mammograms of 61 ductal 
carcinomas (grade 2-3, median age 60, mean tumor size 
28mm). A physician defined a 100x100 ROI around tumors on 
mammographic images. Extraction of texture features was 
performed using three independent descriptors: Local Binary 
Patterns (LBP), Histogram of Oriented Gradients (HOG) and 
Gabor Filter (GF). Then, a supervised classification was 
applied using two independent classifiers: K-Nearest 
Neighbors (KNN) and Support Vector Machines (SVM) (both 
linear- and radial-type). Both classifiers were trained to 
identify the molecular subtype (Luminal A, Luminal B (Her2-), 
Luminal B (Her2+), Her2+, Basal Like and carcinoma in situ) 
using the first 38 mammograms. We assessed the accuracy of 
our machine learning technique using the last 23 
mammograms. 
 
 
Results: Accuracy of SVM-R classifier was 52% irrespective of 
the texture descriptor we used. SVM-L/KNN classifiers 
achieved an accuracy of 48/39, 35/30 and 21/35% for LBP, 
HOG and GF descriptors. When simplifying the classification 
problem to only two subtypes, Luminal A and Luminal B 
(Her2-), classifier accuracies astonishingly improved. SVM-R 
accuracy was 75% irrespective of the texture descriptor and 
SVM(L)/KNN accuracies were 38/75, 50/50 and 63/75% for 
LBP, HOG and GF. 
 
Conclusion: Our texture-feature-driven machine learning 
technique provides a reliable classification into molecular 
subtypes using mammographic images only. Accuracy 
improves when simplifying to only two subtypes. We expect 
even better accuracies by increasing the number of patients 
used for the training stage of our machine learning 
technique. 
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Purpose or Objective: Radiation induced lung toxicity (RILT) 
may occur in 5-20% of patients irradiated due to Non-Small 
Cell Lung Cancer (NSCLC) but may be asymptomatic during 
the course of radiotherapy (RTx). Computed tomography (CT) 
image changes induced by RILT present after 3-9 months 
since RTx, mostly as lung fibrosis. Early changes on lung 
tissue image, i.e. during treatment, are not possible to 
diagnose by the naked eye, but could be detect by computer-
assisted texture analysis. 
 
Material and Methods: Fifteen patients aged 63.7+/-6.4 
years, with NSCLC undergoing RTx were tested using CT 
before RTx and after receiving 40Gy of dose prescribed to 
PTV. Images were entered into a texture analysis program – 
MaZda® which extracted 284 texture parameters based on: 
signal intensity, variability of signal intensity, 
autocorrelation, direction of change, Fourier spectrum, 
Wavelet spectrum and repeatability of intensity change 
patterns. From every patient 10 regions of interest (ROIs) 
